Amedeo Smart

Free Medical Literature Service


 

Amedeo

Multiple Sclerosis

  Free Subscription

19.09.2022

1 Acta Neurol Scand
1 Ann Neurol
2 Brain
1 J Neuroimmunol
2 J Neurol
1 J Neurol Neurosurg Psychiatry
2 J Neurol Sci
1 Nat Rev Neurol
1 Neurology
1 PLoS Biol



    Acta Neurol Scand

  1. ANDREU-CARAVACA L, Ramos-Campo DJ, Chung LH, Manonelles P, et al
    Effects of fast-velocity concentric resistance training in people with multiple sclerosis: A randomized controlled trial.
    Acta Neurol Scand. 2022 Sep 9. doi: 10.1111/ane.13704.
    >> Share


    Ann Neurol

  2. GAUDIOSO CM, Mar S, Casper TC, Codden R, et al
    MOG and AQP4 antibodies among children with multiple sclerosis and controls.
    Ann Neurol. 2022 Sep 11. doi: 10.1002/ana.26502.
    >> Share


    Brain

  3. TONIETTO M, Poirion E, Lazzarotto A, Ricigliano V, et al
    Periventricular remyelination failure in multiple sclerosis: a substrate for neurodegeneration.
    Brain. 2022 Sep 13. pii: 6696508. doi: 10.1093.
    >> Share

  4. TEPAVCEVIC V, Lubetzki C
    Oligodendrocyte progenitor cell recruitment and remyelination in multiple sclerosis: the more, the merrier?
    Brain. 2022 Sep 12. pii: 6696052. doi: 10.1093.
    >> Share


    J Neuroimmunol

  5. FEIZI P, Sharma K, Pasham SR, Nirwan L, et al
    Central nervous system (CNS) inflammatory demyelinating diseases (IDDs) associated with COVID-19: A case series and review.
    J Neuroimmunol. 2022;371:577939.
    >> Share


    J Neurol

  6. NICOLAS P, Marion-Moffet H, Gossez M, Vukusic S, et al
    Anti-SARS-CoV-2 humoral and cellular responses in multiple sclerosis patients treated with anti-CD20 monoclonal antibodies.
    J Neurol. 2022 Sep 12. pii: 10.1007/s00415-022-11353.
    >> Share

  7. KOCH MW, Mostert J, Repovic P, Bowen JD, et al
    The timed 25-foot walk is a more sensitive outcome measure than the EDSS for PPMS trials: an analysis of the PROMISE clinical trial dataset.
    J Neurol. 2022;269:5319-5327.
    >> Share


    J Neurol Neurosurg Psychiatry

  8. WILLUMSEN JS, Grytten N, Aarseth J, Myklebust TA, et al
    Mortality and cause of death in multiple sclerosis in western Norway 1950-2021: a registry-based linkage study.
    J Neurol Neurosurg Psychiatry. 2022 Sep 12. pii: jnnp-2022-329169.
    >> Share


    J Neurol Sci

  9. GROVE CR, Wagner A, Loyd BJ, Dibble LE, et al
    Unique compensatory oculomotor behavior in people living with multiple sclerosis.
    J Neurol Sci. 2022;442:120411.
    >> Share

  10. VISTBAKKA J, Sumelahti ML, Lehtimaki T, Hagman S, et al
    Temporal variability of serum miR-191, miR-223, miR-128, and miR-24 in multiple sclerosis: A 4-year follow-up study.
    J Neurol Sci. 2022;442:120395.
    >> Share


    Nat Rev Neurol

  11. JACOBS BM, Peter M, Giovannoni G, Noyce AJ, et al
    Towards a global view of multiple sclerosis genetics.
    Nat Rev Neurol. 2022 Sep 8. pii: 10.1038/s41582-022-00704.
    >> Share


    Neurology

  12. CAROTENUTO A, Valsasina P, Schoonheim MM, Geurts JJ, et al
    Investigating Functional Network Abnormalities and Associations With Disability in Multiple Sclerosis.
    Neurology. 2022 Sep 12. pii: WNL.0000000000201264.
    >> Share


    PLoS Biol

  13. SMITH KJ, Minns D, McHugh BJ, Holloway RK, et al
    The antimicrobial peptide cathelicidin drives development of experimental autoimmune encephalomyelitis in mice by affecting Th17 differentiation.
    PLoS Biol. 2022;20:e3001554.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016